Shi XC, Gruber JF, Ondari M, Lloyd PC, et al. Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and older. Vaccine 2024 May 3:S0264-410X(24)00478-X. doi: 10.1016/j.vaccine.2024.
PMID: 38704258